HBIO
HBIO
NASDAQ · Life Sciences Tools & Services

Harvard Bioscience Inc

$6.15
+0.03 (+0.41%)
As of Jun 30, 10:47 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +481.3% upside
Low Target $24.20
Average Target $35.75
High Target $46.73
Current Price $6.15
Current
$6.15
Target
$35.75
$24.20 $35.75 avg $46.73
Scenario Analysis
Bear Case
$24.20
293.5%
Low target
Base Case
$35.75
+481.3%
Avg target
Bull Case
$46.73
+659.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$9.40
-34.6% from high
52-Week Low
$3.75
+64.0% from low
Target vs 52W High
$35.75
+280.3% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 34 85% $369.21 -26.4%
DHR
Danaher Corp
Strong Buy 30 90% $158.11 -17.0%
A
Agilent Technologies Inc
Strong Buy 28 79% $64.69 -51.3%
WAT
Waters Corp
Buy 28 57% $189.60 -49.4%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -57.1%
ILMN
Illumina Inc
Buy 28 61% $169.36 -3.7%
MTD
Mettler-Toledo International
Hold 20 50% $170.43 -86.7%
WST
West Pharmaceutical Services
Strong Buy 22 82% $136.24 -62.1%